Anti-LRRK2/Dardarin Antibody

Anti-LRRK2/Dardarin Antibody

• Description: Mouse Monoclonal Antibody specific to LRRK2/Dardarin
• Product Name Alternative: EC 2.7.11.1, EC 3.6.5.-, Dardarin
• CAS Number: 9007-83-4
• Gene Name: LRRK2
• NCBI Gene ID: LRRK2
• UniProt: Q5S007
• Cellular Locus: Cytoplasmic vesicle, Perikaryon, Golgi apparatus membrane, Cell projection, axon, Cell projection, dendrite, Endoplasmic reticulum membrane, Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane, Endosome, Lysosome, Mitochondrion outer membrane
• Host: Mouse
• Reactivity: Human, Mouse, Rat
• Immunogen: Fusion protein corresponding to aa 1-500 (N-terminus) of human LRRK2. This sequence is 83
• Target Antigen: Leucine-rich repeat serine/threonine-protein kinase 2
• Target: LRRK2/Dardarin
• Clonality: Monoclonal
• Isotype: IgG1
• Type: Antibody
• Applications: WB, ICC/IF
• Field of Research: Neuroscience
• Purification Method: Purified by Protein G affinity chromatography
• Concentration: 1.0 mg/mL
• Dilution: Dilute in PBS or medium that is identical to that used in the assay system.
• Format: Purified
• Form: Liquid
• Buffer: Phosphate Buffered Saline
• Function: Serine/threonine-protein kinase which phosphorylates a broad range of proteins involved in multiple processes such as neuronal plasticity, autophagy, and vesicle trafficking (PubMed:20949042, PubMed:22012985, PubMed:26824392, PubMed:29125462, PubMed:28720718, PubMed:29127255, PubMed:30398148, PubMed:29212815, PubMed:30635421, PubMed:21850687, PubMed:23395371, PubMed:17114044, PubMed:24687852, PubMed:26014385, PubMed:25201882). Is a key regulator of RAB GTPases by regulating the GTP/GDP exchange and interaction partners of RABs through phosphorylation (PubMed:26824392, PubMed:28720718, PubMed:29127255, PubMed:30398148, PubMed:29212815, PubMed:29125462, PubMed:30635421). Phosphorylates RAB3A, RAB3B, RAB3C, RAB3D, RAB5A, RAB5B, RAB5C, RAB8A, RAB8B, RAB10, RAB12, RAB35, and RAB43 (PubMed:26824392, PubMed:28720718, PubMed:29127255, PubMed:30398148, PubMed:29212815, PubMed:29125462, PubMed:30635421, PubMed:23395371). Regulates the RAB3IP-catalyzed GDP/GTP exchange for RAB8A through the phosphorylation of 'Thr-72' on RAB8A (PubMed:26824392). Inhibits the interaction between RAB8A and GDI1 and/or GDI2 by phosphorylating 'Thr-72' on RAB8A (PubMed:26824392). Regulates primary ciliogenesis through phosphorylation of RAB8A and RAB10, which promotes SHH signaling in the brain (PubMed:29125462, PubMed:30398148). Together with RAB29, plays a role in the retrograde trafficking pathway for recycling proteins, such as mannose-6-phosphate receptor (M6PR), between lysosomes and the Golgi apparatus in a retromer-dependent manner (PubMed:23395371). Regulates neuronal process morphology in the intact central nervous system (CNS) (PubMed:17114044). Plays a role in synaptic vesicle trafficking (PubMed:24687852). Plays an important role in recruiting SEC16A to endoplasmic reticulum exit sites (ERES) and in regulating ER to Golgi vesicle-mediated transport and ERES organization (PubMed:25201882). Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway (PubMed:22012985). The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes (PubMed:22012985). Phosphorylates PRDX3 (PubMed:21850687). By phosphorylating APP on 'Thr-743', which promotes the production and the nuclear translocation of the APP intracellular domain (AICD), regulates dopaminergic neuron apoptosis (PubMed:28720718). Independent of its kinase activity, inhibits the proteosomal degradation of MAPT, thus promoting MAPT oligomerization and secretion (PubMed:26014385). In addition, has GTPase activity via its Roc domain which regulates LRRK2 kinase activity (PubMed:18230735, PubMed:26824392, PubMed:29125462, PubMed:28720718, PubMed:29212815). {PubMed:17114044, PubMed:18230735, PubMed:20949042, PubMed:21850687, PubMed:22012985, PubMed:23395371, PubMed:24687852, PubMed:25201882, PubMed:26014385, PubMed:26824392, PubMed:28720718, PubMed:29125462, PubMed:29127255, PubMed:29212815, PubMed:30398148, PubMed:30635421}.
• Additionnal Information: Immunoblotting: use at 1-5ug/mL. A band of >200kDa is detected.
  
  Immunofluorescence: use at 10ug/mL.
  
  These are recommended concentrations.
  
  Endusers should determine optimal concentrations for their application.
• Storage Conditions: This product is stable for at least one (1) year at -20°C.
• Specificity: This antibody recognizes human, mouse and rat LRRK2.
• Formulation: PBS, pH 7.4, 0.1% sodium azide, 50% glycerol.
• Buffer pH: pH 7.4
• Target Background: LRRK2 is a large protein (>200kDa) with multiple domains including several ankyrin, leucine-rich, and WD40 repeats, a Raslike small GTPase family domain named Roc, and a kinase domain that is closely related to the RIP kinase domain. The LRRK2 gene is expressed in brain as well as in other tissues such as lung, liver and heart. LRRK2 might be central to the pathogenesis of several major neurodegenerative diseases associated with parkinsonism. LRRK2 is also known as Leucine-rich repeat serine/threonine-protein kinase 2, Dardarin, and PARK8.